Dolphin Medical Services Ltd
Incorporated in 1984, Dolphin Medical Services Ltd is in the business of diagnostics and
other allied services.[1]
- Market Cap ₹ 9.51 Cr.
- Current Price ₹ 6.29
- High / Low ₹ 9.57 / 1.98
- Stock P/E
- Book Value ₹ 8.45
- Dividend Yield 0.00 %
- ROCE -0.05 %
- ROE -0.39 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.71 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -32.5% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -3.73% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.60 | 2.70 | 3.35 | 4.06 | 3.76 | 1.14 | 0.96 | 0.36 | 0.57 | |
| 2.07 | 2.14 | 2.24 | 2.82 | 2.83 | 1.73 | 1.06 | 0.39 | 0.39 | |
| Operating Profit | 0.53 | 0.56 | 1.11 | 1.24 | 0.93 | -0.59 | -0.10 | -0.03 | 0.18 |
| OPM % | 20.38% | 20.74% | 33.13% | 30.54% | 24.73% | -51.75% | -10.42% | -8.33% | 31.58% |
| 0.14 | 0.05 | 0.07 | 0.14 | -0.54 | -0.01 | 0.00 | 0.01 | 0.15 | |
| Interest | 0.11 | 0.02 | 0.54 | 0.67 | 1.19 | 0.70 | 0.05 | 0.05 | 0.06 |
| Depreciation | 0.31 | 0.39 | 0.57 | 0.59 | 0.65 | 0.65 | 0.71 | 0.52 | 0.34 |
| Profit before tax | 0.25 | 0.20 | 0.07 | 0.12 | -1.45 | -1.95 | -0.86 | -0.59 | -0.07 |
| Tax % | 44.00% | 35.00% | 228.57% | 100.00% | 2.76% | 1.54% | 0.00% | -3.39% | -28.57% |
| 0.14 | 0.13 | -0.09 | 0.00 | -1.49 | -1.98 | -0.86 | -0.57 | -0.05 | |
| EPS in Rs | 0.09 | 0.09 | -0.06 | 0.00 | -0.99 | -1.31 | -0.57 | -0.38 | -0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -21% |
| TTM: | 58% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 25% |
| TTM: | 91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 15% |
| 3 Years: | 49% |
| 1 Year: | 178% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -6% |
| 3 Years: | -4% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves | 2.57 | 2.70 | 2.61 | 2.61 | 1.12 | -0.86 | -1.72 | -2.30 | -2.34 |
| 0.17 | 5.49 | 6.94 | 6.99 | 7.69 | 8.24 | 8.10 | 8.05 | 8.16 | |
| 0.45 | 0.45 | 0.63 | 0.86 | 0.79 | 0.82 | 0.83 | 0.82 | 0.75 | |
| Total Liabilities | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
| 7.47 | 8.50 | 12.14 | 15.69 | 11.40 | 11.94 | 11.23 | 14.69 | 14.34 | |
| CWIP | 0.00 | 8.14 | 6.64 | 3.28 | 7.29 | 6.10 | 6.11 | 2.14 | 2.14 |
| Investments | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| 10.41 | 6.69 | 6.09 | 6.18 | 5.60 | 4.85 | 4.56 | 4.43 | 4.78 | |
| Total Assets | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 1.36 | 0.00 | 1.30 | 0.15 | 0.19 | -0.12 | |||
| -9.57 | -3.23 | 0.00 | -0.50 | -0.12 | -0.17 | 0.01 | |||
| 5.19 | 1.37 | 0.00 | -0.88 | -0.03 | -0.02 | 0.11 | |||
| Net Cash Flow | -2.38 | -0.50 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | ||
| Free Cash Flow | -7.56 | -1.35 | 0.00 | 1.23 | 0.16 | 0.19 | -0.11 | ||
| CFO/OP | 357% | 123% | 0% | 140% | -25% | -190% | -67% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 13.86 | 21.22 | 45.62 | 36.50 | 36.50 | 21.47 | |||
| Days Payable | 13.86 | 4.24 | 0.00 | 12.17 | 73.00 | 0.00 | |||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.90 | 16.98 | 45.62 | 24.33 | -36.50 | 21.47 |
| Working Capital Days | 1,037.44 | 462.33 | 306.16 | 265.21 | 245.60 | 582.72 | 589.32 | 1,449.86 | 1,171.84 |
| ROCE % | 1.07% | 2.54% | 3.20% | 1.15% | -5.33% | -3.67% | -2.54% | -0.05% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Shares in Dematerialized Form % of share capital ・Standalone data |
|
||||||||
| Total Number of Shareholders count ・Standalone data |
|||||||||
| Promoter Holding % of share capital ・Standalone data |
|||||||||
| Number of Promoter Shareholders count ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for To Consider And Approve The Appointment Of Mr. Amarandhar Reddy Kotha (DIN: 07425226) As Chairman And Promoter Director Of The Company And Other Items
- Board meets 21 Sept 2026 to appoint chairman, reclassify promoter status, and reconstitute committees.
-
Board Meeting Outcome for Intimation Of Resignation Of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA And Mr. DWARAKANATH MADALA
- Board noted immediate resignations of MD&CEO G V Mohan Prasad and directors Lakshmi Sudha Madala, Dwarkanath Madala on 12 Sep 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board noted immediate resignations of MD/CEO G V Mohan Prasad and two directors on 12 Sept 2026.
-
Intimation Of Extension Of AGM
- ROC granted Dolphin Medical Services a two-month AGM extension until November 30, 2026.
-
Post-Offer Advertisement
- Post-offer ad: acquirers bought 18,000 of 39,25,988 shares at ₹4.80 on Aug 21, 2026.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
a) DMSL provides a range of tests covering Radiology and Imaging, Biochemistry, Pathology, and Microbiology, etc., to the people of the coastal region of Andhra Pradesh.
b) Additionally, it has the eye care
division called the Dolphin Nethralaya
which is a comprehensive eye care
and a laser and research centre.
c) The company has also ventured
into IT and Biotechnology and Herbal
sectors